Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02160717 · ClinicalTrials.gov registry record

Risk of Diabetes in Young Turner Syndrome Patients

A clinical trial of Turner Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
120
Enrollment target
1
Study location

NCT02160717 is a study of Turner Syndrome that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 120 participants, below the 511-participant average among 14 other Turner Syndrome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02160717, a study of Turner Syndrome, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objective of this study is to determine if there are abnormalities in glucose metabolism and pancreatic function in young girls with Turner Syndrome. The study hypothesis is that pancreatic dysfunction (specifically of the beta cells that make insulin) is more prevalent in girls with Turner Syndrome compared to healthy controls.

Conditions Studied

Study Locations (1)

Ohio

  • Children's Hospital Medical Center, Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2014-05
Est. Completion 2017-06

What the Registry Record Tells You About NCT02160717

The ClinicalTrials.gov registry entry for NCT02160717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 511-participant average among 14 other Turner Syndrome trials with a reported enrollment target (77% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Turner Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT02160717 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02160717 about?

NCT02160717 is a clinical study titled "Risk of Diabetes in Young Turner Syndrome Patients". Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objec...

What is the current status of trial NCT02160717?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-05. Estimated completion is 2017-06.

What conditions does trial NCT02160717 study?

This clinical trial studies the following conditions: Turner Syndrome.

Who is sponsoring clinical trial NCT02160717?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02160717 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Turner Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.